Figure 2From: Characterization and assessment of the sensitivity and resistance of a newly established human gastrointestinal stromal tumour xenograft model to treatment with tyrosine kinase inhibitorsRelative evolution of tumour volume in UZLX-GIST9 xenografts under treatment with different TKIs. Data for tumour volume evolution are displayed as means and standard error of the means.Back to article page